Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

White Paper

Apixaban API – ready-to-compress granules and finished dosage forms

Dr. Reddy's is among the earliest global generic API manufacturers for Apixaban API and filed the USDMF in September 2015. Our customers have access to the high-quality API in customized particle sizes to facilitate formulation development.

Apixaban is an anticoagulant medication approved under the trade name Eliquis in Europe in 2011, and in the US in 2012. It was first approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Read the technical sheet on this topic by filling the contact form below.
 

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper

Email us: api@drreddys.com | +91 40 49002222

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.